PHASE Scientific | INDICAID health At-Home Self-Testing For Common Conditions

Connect With Us

Inspiring A New State of Health

Inspiring A New State of Health

Our innovative diagnostic offerings support everyone to better understand and manage their own health

View Our Products & Services

INDICAID health

INDICAID health

Empower your customers, boost your business and unlock a healthier tomorrow with At-Home Collection Kits.

Partner With Us

INDICAID OTC

Over-the-counter rapid antigen tests
focused on the detection of infectious diseases

INDICAID POC

Point-of-care rapid antigen tests
focused on the detection of infectious diseases

Revolutionizing

Revolutionizing

Healthcare Through Better Insight

Founded in 2015 as a spin-off from UCLA's bioengineering program, PHASE Scientific Americas is a fast-growing biotechnology company dedicated to inspiring a new state of health. We are committed to providing innovative diagnostic and data tools needed to make better health decisions.

Our comprehensive product offerings are designed to address and fulfill a wide spectrum of market needs, making quality diagnostic testing more accessible to patients and providers.

INDICAID: OTC and POC rapid antigen tests focused on the detection of common diseases and conditions

INDICAID health: Digital health platform offering at-home collection testing and virtual care services

PHASiFY: Proprietary sample preparation technology to advance molecular diagnostic testing

PHASE Lab: CLIA certified and CAP accredited high complexity lab

Our mission is clear: to redefine diagnostic testing through innovative technologies. PHASE Scientific Americas is at the forefront of transforming healthcare diagnostics.

Our Product & Services

INDICAID health

INDICAID health

INDICAID health enables your customers to take control of their own health with easy-to-use at-home collection kits.

INDICAID PoC

INDICAID (PoC) COVID-19 Rapid Antigen Test (FDA EUA) is a lateral flow immunoassay for professional use.

INDICAID OTC

INDICAID OTC is a fast, reliable, and affordable COVID-19 Rapid Antigen At-Home Test (FDA EUA).

Our Focus Areas

Cancer

Infectious Diseases

Infectious Diseases

Infectious Diseases

Stay in the loop! Subscribe to our newsletter for the latest company updates.

Sign Up For Our Insights Newsletter Today

Featured News

PHASE Scientific Americas Announces INDICAID Health™ At-Home Test Kits and Digital Health Platform

PHASE Scientific Americas Announces INDICAID Health™ At-Home Test Kits and Digital Health Platform

October 25, 2023

COVID-19 Omicron EG.5 Variant Update

COVID-19 Omicron EG.5 Variant Update

August 16, 2023

Sick Patients? Do you still need to test them for COVID-19? Experts Say There is One Easy Answer.

Sick Patients? Do you still need to test them for COVID-19? Experts Say There is One Easy Answer.

September 26, 2023

The Diagnostic Partner: Addressing the Equity Implications of Health Diagnostics

The Diagnostic Partner: Addressing the Equity Implications of Health Diagnostics

February 27, 2023

US Government Suspending Free At-Home COVID-19 Test Program

US Government Suspending Free At-Home COVID-19 Test Program

September 11, 2022

Targeting COVID-19 Absenteeism with Test to Treat Approach

Targeting COVID-19 Absenteeism with Test to Treat Approach

September 6, 2022

How Often Can I Be Infected with the Coronavirus?

How Often Can I Be Infected with the Coronavirus?

July 15, 2022

EUA for INDICAID to Cover Serial Testing for Asymptomatic Individuals

EUA for INDICAID to Cover Serial Testing for Asymptomatic Individuals

September 29, 2021

INDICAID COVID-19 Rapid Antigen Test Receives EUA From the U.S. FDA

INDICAID COVID-19 Rapid Antigen Test Receives EUA From the U.S. FDA

August 10, 2021

Performance of the INDICAID COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)

Performance of the INDICAID COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)

February 1, 2022

Hong Kong’s Hospitals Reach a Breaking Point as Infections Skyrocket

Hong Kong’s Hospitals Reach a Breaking Point as Infections Skyrocket

March 1, 2022

PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests

PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests

April 25, 2022

INDICAID COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)

INDICAID COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)

May 24, 2022

PHASE Scientific Donates 600 of its INDICAID COVID-19 Rapid Antigen At-Home Tests for CancerCon in Minneapolis June 9-12

PHASE Scientific Donates 600 of its INDICAID COVID-19 Rapid Antigen At-Home Tests for CancerCon in Minneapolis June 9-12

May 20, 2022

Here’s How Long Some Popular At-Home Virus Test Kits Actually Last, According To The FDA

Here’s How Long Some Popular At-Home Virus Test Kits Actually Last, According To The FDA

June 1, 2022

SCOTUS Block on OSHA’s Emergency Temporary Standard

SCOTUS Block on OSHA’s Emergency Temporary Standard

January 20, 2022

Update on SCOTUS and the COVID-19 Vaccine Testing Mandate

Update on SCOTUS and the COVID-19 Vaccine Testing Mandate

January 27, 2022

This COVID-19 Wave Might Be The Start Of Our ‘New Normal’

This COVID-19 Wave Might Be The Start Of Our ‘New Normal’

June 11, 2022

Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On

Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On

March 31, 2022

Pandemic to Endemic

Pandemic to Endemic

January 27, 2022

A Premium At-Home COVID-19 Rapid Antigen Testing Product Hits U.S. Retail Stores

A Premium At-Home COVID-19 Rapid Antigen Testing Product Hits U.S. Retail Stores

March 28, 2022

FAQS About Families First Coronavirus Response Act

FAQS About Families First Coronavirus Response Act

February 4, 2022

OSHA Vaccine Mandate

OSHA Vaccine Mandate

January 6, 2022

AMA Updated Coding Guidelines

AMA Updated Coding Guidelines

February 25, 2022

What is the message for employers dealing with Omicron and other variants?

What is the message for employers dealing with Omicron and other variants?

December 23, 2021

What is the message for employers dealing with Omicron and other variants?

What is the message for employers dealing with Omicron and other variants?

December 23, 2021

Shallow Nasal Swabbing for Improved Patient Comfort

Shallow Nasal Swabbing for Improved Patient Comfort

September 1, 2022

PHASE Scientific Global Headquarters Opening - A New Chapter

PHASE Scientific Global Headquarters Opening - A New Chapter

November 3, 2022

Phase Scientific Donates Tests to International Community

Phase Scientific Donates Tests to International Community

August 5, 2021

PHASE Scientific Announces CE Mark Approval for the PHASIFY™ VIRAL RNA Extraction Kit

PHASE Scientific Announces CE Mark Approval for the PHASIFY™ VIRAL RNA Extraction Kit

July 20, 2020

Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications

Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications

June 22, 2020

Hong Kong Gives Biotech a Chance

Hong Kong Gives Biotech a Chance

June 1, 2019

Kenya Grants Emergency Use Authorization for the INDICAID COVID-19 Rapid Antigen Test

Kenya Grants Emergency Use Authorization for the INDICAID COVID-19 Rapid Antigen Test

August 30, 2021

Bill Gates Backed Biotech in Diagnostic Push

Bill Gates Backed Biotech in Diagnostic Push

June 7, 2019

New York State Selects COVID-19 Diagnostics Leaders to Expand Testing Options

New York State Selects COVID-19 Diagnostics Leaders to Expand Testing Options

October 12, 2022

Phase Scientific Charters Planes to Fly Tests To The US

Phase Scientific Charters Planes to Fly Tests To The US

December 23, 2021

PHASE Scientific Donates More than 2,000 INDICAID COVID-19 Tests to Atlanta Public Schools Back to School Bash

PHASE Scientific Donates More than 2,000 INDICAID COVID-19 Tests to Atlanta Public Schools Back to School Bash

July 27, 2022

New Office Opens In Georgia

New Office Opens In Georgia

February 14, 2022

PHASE Scientific Americas and Dr. B Partner to Make It Easier Than Ever To Test-To-Treat COVID-19 At Home

PHASE Scientific Americas and Dr. B Partner to Make It Easier Than Ever To Test-To-Treat COVID-19 At Home

December 21, 2022

The Diagnostic Partner: Expanding The Use of Test-to-Treat in the Post-pandemic World

The Diagnostic Partner: Expanding The Use of Test-to-Treat in the Post-pandemic World

February 21, 2023

INDICAID COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration

INDICAID COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration

August 11, 2021

Why Employers Should Not Remove Their COVID-19 Testing Polices

Why Employers Should Not Remove Their COVID-19 Testing Polices

December 5, 2022

New Study: Employers’ COVID-19 Testing Support For At-Home Testing Grows

New Study: Employers’ COVID-19 Testing Support For At-Home Testing Grows

October 6, 2022

Omicron Variant Update

Omicron Variant Update

November 21, 2022

INDICAID’S Omicron Variant Update

INDICAID’S Omicron Variant Update

April 4, 2022

With Support From